References
-
1
Tombran-Tink J, Barnstable CJ.
Nat Rev Neurosci.
2003;
4
628-636
-
2
Miyamoto K, Khosrof S, Bursell SE, Rohan R, Murata T, Clermont AC, Aiello LP, Ogura Y, Adamis AP.
Proc Natl Acad Sci USA.
1999;
96
10836-10841
-
3
Nakamura H, Inoue T, Arakawa N, Shimizu Y, Yoshigae Y, Fujimori I, Shimakawa E, Toyoshi T, Yokoyama T.
Eur J Pharmacol.
2005;
512
239-246
-
4
Nagisa Y, Shintani A, Nakagawa S.
Diabetologia.
2001;
44
883-888
-
5
Yamagishi S, Inagaki Y, Nakamura K, Abe R, Shimizu T, Yoshimura A, Imaizumi T.
J Mol Cell Cardiol.
2004;
3
497-506
-
6
Staunton DE, Marlin SD, Stratowa C, Dustin ML, Springer TA.
Cell.
1988;
52
925-933
-
7
Yamagishi S, Takeuchi M.
Drugs Exp Clin Res.
2004;
30
163-168
-
8
Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP.
FASEBJ.
2004;
18
1450-1452
-
9
van Reyk DM, Gillies MC, Davies MJ.
Redox Rep.
2003;
8
187-192
-
10
Mamputu JC, Renier G.
J Leukoc Biol.
2004;
75
1062-1069
Correspondence
Dr. Sho-ichi Yamagishi
Department of Internal Medicine III·Kurume University School of Medicine
67 Asahi-machi·Kurume 830-0011·Japan
Phone: +81/942/31 75 80
Fax: +81/942/31 77 07
Email: shoichi@med.kurume-u.ac.jp
